233 related articles for article (PubMed ID: 30207281)
1. A pilot study evaluating chemotherapy tolerability for breast cancer patients who have received prior treatment and chest radiation for Hodgkin Lymphoma.
Watson AP; Peterson B; Lee C; Baxstrom K; Turcotte L; Vogel R; Blaes A
Cancer Treat Res Commun; 2018; 15():1-6. PubMed ID: 30207281
[TBL] [Abstract][Full Text] [Related]
2. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
[TBL] [Abstract][Full Text] [Related]
3. Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.
Conway JL; Connors JM; Tyldesley S; Savage KJ; Campbell BA; Zheng YY; Hamm J; Pickles T
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):35-41. PubMed ID: 27979454
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohort.
Wong SM; Ajjamada L; Weiss AC; Prakash I; Skamene S; Boileau JF; Pollak MN; Basik M
Cancer; 2022 Apr; 128(7):1365-1372. PubMed ID: 34919263
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study.
Elkin EB; Klem ML; Gonzales AM; Ishill NM; Hodgson D; Ng AK; Marks LB; Weidhaas J; Freedman GM; Miller RC; Constine LS; Myrehaug S; Yahalom J
J Clin Oncol; 2011 Jun; 29(18):2466-73. PubMed ID: 21576642
[TBL] [Abstract][Full Text] [Related]
6. Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.
van Eggermond AM; Schaapveld M; Janus CP; de Boer JP; Krol AD; Zijlstra JM; van der Maazen RW; Kremer LC; van Leerdam ME; Louwman MW; Visser O; De Bruin ML; Aleman BM; van Leeuwen FE
Br J Cancer; 2017 Jul; 117(3):306-314. PubMed ID: 28632726
[TBL] [Abstract][Full Text] [Related]
7. Taxane-based regimens as a risk factor for chemotherapy-induced amenorrhea.
Najafi S; Djavid GE; Mehrdad N; Rajaii E; Alavi N; Olfatbakhsh A; Najafi M; Bahrami A; Heidari K
Menopause; 2011 Feb; 18(2):208-12. PubMed ID: 21037487
[TBL] [Abstract][Full Text] [Related]
8. Final results of an international retrospective observational study in patients with advanced breast cancer treated with oral vinorelbine-based chemotherapy.
Palomo AG; Glogowska I; Sommer H; Malamos N; Kilar E; Vega JM; Torrecillas L; Delozier T; Ettl J; Finek J
Anticancer Res; 2012 Oct; 32(10):4539-45. PubMed ID: 23060583
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Pathologic Response Evaluation Systems after Anthracycline with/without Taxane-Based Neoadjuvant Chemotherapy among Different Subtypes of Breast Cancers.
Lee HJ; Park IA; Song IH; Kim SB; Jung KH; Ahn JH; Ahn SH; Kim HH; Gong G
PLoS One; 2015; 10(9):e0137885. PubMed ID: 26394326
[TBL] [Abstract][Full Text] [Related]
10. Optimal radiation dose for patients with one to three lymph node positive breast cancer following breast-conserving surgery and anthracycline plus taxane-based chemotherapy: A retrospective multicenter analysis (KROG 1418).
Kim H; Park W; Yu JI; Choi DH; Huh SJ; Kim YJ; Lee ES; Lee KS; Kang HS; Park IH; Shin KH; Kim K; Park KR; Kim YB; Ahn SJ; Lee JH; Kim JH; Chun M; Lee HS; Kim JS; Lee JY
Oncotarget; 2017 Jan; 8(1):1796-1804. PubMed ID: 27793036
[TBL] [Abstract][Full Text] [Related]
11. Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant anthracycline and taxane.
Okanami Y; Ito Y; Watanabe C; Iijima K; Iwase T; Tokudome N; Takahashi S; Hatake K
Breast Cancer; 2011 Jul; 18(3):182-8. PubMed ID: 21394515
[TBL] [Abstract][Full Text] [Related]
12. Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma.
Opstal-van Winden AWJ; de Haan HG; Hauptmann M; Schmidt MK; Broeks A; Russell NS; Janus CPM; Krol ADG; van der Baan FH; De Bruin ML; van Eggermond AM; Dennis J; Anton-Culver H; Haiman CA; Sawyer EJ; Cox A; Devilee P; Hooning MJ; Peto J; Couch FJ; Pharoah P; Orr N; Easton DF; Aleman BMP; Strong LC; Bhatia S; Cooke R; Robison LL; Swerdlow AJ; van Leeuwen FE
Blood; 2019 Mar; 133(10):1130-1139. PubMed ID: 30573632
[TBL] [Abstract][Full Text] [Related]
13. Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure.
Krul IM; Opstal-van Winden AWJ; Aleman BMP; Janus CPM; van Eggermond AM; De Bruin ML; Hauptmann M; Krol ADG; Schaapveld M; Broeks A; Kooijman KR; Fase S; Lybeert ML; Zijlstra JM; van der Maazen RWM; Kesminiene A; Diallo I; de Vathaire F; Russell NS; van Leeuwen FE
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):843-853. PubMed ID: 28888722
[TBL] [Abstract][Full Text] [Related]
14. Effects of adding taxane to anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer.
Rašić A; Sofić A; Bešlija S; Rašić I; Hasanbegović B
Med Glas (Zenica); 2019 Feb; 16(1):77-82. PubMed ID: 30256061
[TBL] [Abstract][Full Text] [Related]
15. A pilot investigation on impact of participation in a long-term follow-up clinic (LTFU) on breast cancer and cardiovascular screening among women who received chest radiation for Hodgkin lymphoma.
Baxstrom K; Peterson BA; Lee C; Vogel RI; Blaes AH
Support Care Cancer; 2018 Jul; 26(7):2361-2368. PubMed ID: 29417294
[TBL] [Abstract][Full Text] [Related]
16. Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial.
Lambertini M; Bruzzi P; Poggio F; Pastorino S; Gardin G; Clavarezza M; Bighin C; Pronzato P; Del Mastro L
Support Care Cancer; 2016 Mar; 24(3):1285-94. PubMed ID: 26306520
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of breast cancer occurring after treatment for Hodgkin's lymphoma: case-control analysis.
Alm El-Din MA; Hughes KS; Raad RA; Goldberg SI; Aisenberg AC; Niemierko A; Taghian AG
Radiat Oncol; 2009 Jun; 4():19. PubMed ID: 19566943
[TBL] [Abstract][Full Text] [Related]
18. Cervical non-squamous carcinoma: an effective combination chemotherapy of taxane, anthracycline and platinum for advanced or recurrent cases.
Kimura T; Miyatake T; Ueda Y; Ohta Y; Enomoto T; Kimura T; Kamiura S
Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):200-4. PubMed ID: 22770633
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer after treatment of Hodgkin's disease.
Hancock SL; Tucker MA; Hoppe RT
J Natl Cancer Inst; 1993 Jan; 85(1):25-31. PubMed ID: 8416252
[TBL] [Abstract][Full Text] [Related]
20. Management of breast cancer after Hodgkin's lymphoma and paediatric cancer.
Terenziani M; Massimino M; Magazzù D; Gandola L; Capri G; Carcangiu ML; Catania S; Di Russo A; Gennaro M; Meazza C; Podda M; Schiavello E; Valagussa P
Eur J Cancer; 2015 Sep; 51(13):1667-74. PubMed ID: 26092639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
